snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    snackbar-icon
    title
    message
    Search Startups

    Active, Cells technology, Small Startups

    Processing your search... This may take a moment
    61 Startups 1 In the News 2 Recently Updated
    • Total Funding
      $241.1M
      Raised
      64
      Events
    • Private Funding
      $136.1M
      Raised
      58
      Rounds
    • Public Offerings
      $500K
      Raised
      2
      Offerings
    • M&A
      $104.5M
      Raised
      4
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Lutris Pharma logo

    Lutris Pharma

    Anticancer Therapy for Patients Treated with EGFR Inhibitors
    2015 B2B 1-10 Seed $40.69M
    topical-treatment
    cell-therapy
    cancer
    pharma-companies
    pharmaceuticals
    dermatology
    cancer-therapy
    Viritis logo

    Viritis

    Next-generation antisense-based antiviral treatments
    2023 B2B 1-10 Pre-Seed $665K
    pharmaceuticals
    vaccines
    oral-drugs
    therapeutics
    drug-delivery
    treatments
    viral-diseases
    biotechnology
    biopharmaceutical
    drug-design
    nanotechnology
    AnserBio logo

    AnserBio

    Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
    2017 B2B 1-10 Seed $6.45M
    biotechnology
    medical-technologies
    therapeutics
    oncology
    cancer
    cell-therapy
    nanotechnology
    ApoRx Biopharmaceuticals logo

    ApoRx Biopharmaceuticals

    Targeted Protein Degradation Drug Discovery
    2021 B2B 1-10 Pre-Funding Undisclosed
    oncology
    pharmaceuticals
    immunotherapy
    pharma-companies
    biotechnology
    drug-discovery
    drug-design
    biopharmaceutical
    cancer-therapy
    cancer
    Betalin Therapeutics logo

    Betalin Therapeutics

    Tissue Engineering for Insulin Therapy Alternative
    2015 B2B2C 1-10 A $11.06M
    bioconvergence
    diabetes
    cell-therapy
    biological-therapy
    regenerative-medicine
    biopharmaceutical
    biotechnology
    chronic-patients
    treatments
    Bioimmunate Technologies logo

    Bioimmunate Technologies

    Blood Filtering Technology for Autoimmune Diseases
    2014 B2B2C 1-10 Seed $1.95M
    multiple-sclerosis
    medical-technologies
    medical-devices
    hospitals
    patients
    autoimmune-diseases
    bioconvergence
    Biokine Therapeutics logo

    Biokine Therapeutics

    Anticancer and Stem Cell Mobilization Drugs
    2000 B2C 1-10 Mature $1.95M
    stem-cells
    biopharmaceutical
    bioprocess
    cancer
    drug-discovery
    doctors
    autoimmune-diseases
    patients
    healthcare-providers
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    61 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $241.1M
      Raised
      64
      Events
    • Private Funding
      $136.1M
      Raised
      58
      Rounds
    • Public Offerings
      $500K
      Raised
      2
      Offerings
    • M&A
      $104.5M
      Raised
      4
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Lutris Pharma logo
    Raised
    $40.69M
    Lutris Pharma
    Anticancer Therapy for Patients Treated with EGFR Inhibitors
    Founded:2015
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Viritis logo
    Raised
    $665K
    Viritis
    Next-generation antisense-based antiviral treatments
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Seed
    AnserBio logo
    Raised
    $6.45M
    AnserBio
    Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    ApoRx Biopharmaceuticals logo
    Raised
    Undisclosed
    ApoRx Biopharmaceuticals
    Targeted Protein Degradation Drug Discovery
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Betalin Therapeutics logo
    Raised
    $11.06M
    Betalin Therapeutics
    Tissue Engineering for Insulin Therapy Alternative
    Founded:2015
    Business Model:B2B2C
    Employees:1-10
    Funding Stage:A
    Bioimmunate Technologies logo
    Raised
    $1.95M
    Bioimmunate Technologies
    Blood Filtering Technology for Autoimmune Diseases
    Founded:2014
    Business Model:B2B2C
    Employees:1-10
    Funding Stage:Seed
    Biokine Therapeutics logo
    Raised
    $1.95M
    Biokine Therapeutics
    Anticancer and Stem Cell Mobilization Drugs
    Founded:2000
    Business Model:B2C
    Employees:1-10
    Funding Stage:Mature
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,